LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
LabCorp is Scheduled to Present at the Barclays Capital 2012 Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Barclays Capital 2012 Global Healthcare Conference
LabCorp is Scheduled to Speak at RBC Capital Markets’ 2012 Global Healthcare Conference Read more about LabCorp is Scheduled to Speak at RBC Capital Markets’ 2012 Global Healthcare Conference
Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results Read more about Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results
LabCorp to Offer New FDA Cleared Test to Aid in Assessing Whether Ovarian Mass is at High or Low Likelihood of Being Malignant Read more about LabCorp to Offer New FDA Cleared Test to Aid in Assessing Whether Ovarian Mass is at High or Low Likelihood of Being Malignant
LabCorp is Scheduled to Present at the 30th Annual J.P. Morgan Healthcare Conference Read more about LabCorp is Scheduled to Present at the 30th Annual J.P. Morgan Healthcare Conference
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp(R) Enters into New Credit Facility Totaling $1.0 Billion Read more about LabCorp(R) Enters into New Credit Facility Totaling $1.0 Billion
LabCorp Successfully Completes Acquisition of Orchid Cellmark Inc. Read more about LabCorp Successfully Completes Acquisition of Orchid Cellmark Inc.
LabCorp Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Additional Tenders Read more about LabCorp Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Additional Tenders
